Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-31

Clinical Trial Update: Prognostic Value of Circulating Endothelial Progenitor Cells in Aneurysmal Subarachnoid Hemorrhage

View source ↗

Summary

This clinical trial update discusses whether circulating endothelial progenitor cells have prognostic value for outcomes in aneurysmal subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Aneurysmal Subarachnoid Hemorrhage | Status: UNKNOWN